| Our team of gynecologic oncologists offers a full spectrum of cancer-related care. In addition to traditional options, we provide several unique services and approaches to cancer for the benefit of our patients.
|
Laparoscopy: For many women, cancer surgery requires an abdominal incision and lengthy postoperative recovery. For some of these women, our trained specialists can offer laparoscopy.
Laparoscopy can be performed through a few inch-long abdominal incisions. In general, laparoscopy offers patients a shorter hospital stay, quicker recovery, decreased risk of infection, and lower costs.
Many hysterectomies, lymph node removals, and some ovarian mass excisions can be performed using this technique.
|
|
|
|
 |
Genetic counseling: Although our experts are trained in the treatment of cancers of the female reproductive tract, prevention is another important goal. Many women affected by these cancers have concerns, not only for their own health, but also for the health of other family members.
|
|
Therefore, prevention is the primary focus at the Hereditary Gynecologic Cancer program. Begun in September 2000, the program offers assessment, counseling, preventive surgery, and medical management to patients with increased risks for cancers of the female reproductive organs. Working in conjunction with a genetic counselor, our cancer specialists can determine whether these cancers in a given family are hereditary. Physicians can then provide risk assessment and counseling to patients and their families.
|
|
|
Fistula Repair: Extensive cancer surgeries or radiation therapy may successfully remove life-threatening cancers. Unfortunately for some women, the tissue damage and poor healing that follows these treatments may lead to permanent holes, called fistulas, in the bladder or rectum. As a result, patients may note chronic and continuous loss of stool or urine passing through the vagina.
For some women, this complication of cancer therapy leads to corrective surgeries called ostomy procedures. These procedures redirect stool or urine to drain into an external pouch on the abdomen.
Fortunately for many women, fistulas can be repaired and permanent ostomy use avoided. Our specialists in cancer surgery can offer this corrective surgery when necessary following cancer treatment.
|
 |
|
 |
The Simmons Comprehensive Cancer Center: This facility houses a broad-based collection of cancer programs, each providing a wide range of patient care services. Our team of physicians and their support staffs, representing virtually every clinical department at the medical center, is devoted to our patients' health and well-being through the blending of leading edge cancer research with the best of conventional cancer care. We strive to be at the forefront of patient care by providing state-of-the-art diagnostic and therapeutic approaches that are specific to each patient's need.
|
We invite you to read and learn more about the cancer specialists in our department.
|
Dr. David Scott Miller is Chief of the Gynecologic Oncology Division in the Department of Obstetrics and Gynecology and Medical Director for the division's University Practice. He completed his training in Obstetrics and Gynecology at the Medical College of Pennsylvania. He gained advanced training during his fellowship in Reproductive Endocrinology at the University of California-San Diego. He achieved additional fellowship training in Gynecologic Oncology at Stanford University Medical Center.
|
David Scott Miller, M.D.
Medical Director
|
|
|
 |
Dr. Miller is a Professor in Obstetrics and Gynecology and holds the Dallas Foundation Chair in Gynecologic Oncology. He is widely known as an authority on gynecologic oncology with hundreds of publications and lectures to his credit. He is a member of several specialty organizations. Among them are the Gynecologic Oncology Group, the American Society of Clinical Oncology, the Society of Gynecologic Oncologists, the American Radium Society, the American Cancer Society, and the International Gynecologic Cancer Society.
Dr. Miller is also a member of the American College of Obstetricians and Gynecologists. He serves as an examiner for the American Board of Obstetrics and Gynecology where he participates in the oral examination of physicians seeking board certification in gynecology oncology.
|
|
|
|
Dr. John Schorge is an Associate Professor at UT Southwestern and serves as Fellowship Director for the Gynecologic Oncology Division in the Department of Obstetrics and Gynecology.
Dr. Schorge earned his medical degree from Vanderbilt University School of Medicine. He completed both his residency education in Obstetrics and Gynecology and his specialty training in Gynecologic Oncology at Harvard Medical School's Brigham and Women's Hospital and Massachusetts General Hospital.
|
John Schorge, M.D. |
|
|
|
Dr. Schorge holds the Patricia Duniven Fletcher Distinguished Professorship in Gynecologic Oncology. He is a member of several organizations including the American College of Obstetricians and Gynecologists, Gynecologic Oncology Group, American Society of Clinical Oncology, Society of Gynecologic Oncologists, American Association for Cancer Research, American College of Surgeons, and Society for Gynecologic Investigation.
In addition to caring for patients, Dr. Schorge is active in both laboratory and clinical research and has lectured and published extensively on topics in gynecologic oncology.
|
|
Jayanthi S. Lea, M.D. is an Assistant Professor in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology. She is a member of the Society of Gynecologic Oncologists, the American College of Obstetricians and Gynecologists and American Society of Clinical Oncologists.
She earned her medical degree from East Carolina University School of Medicine and completed her residency training in Obstetrics and Gynecology at Riverside Methodist Hospital in Columbus, Ohio. Following residency, Dr. Lea completed a four-year Gynecologic Oncology Fellowship at UT Southwestern. Dr. Lea was also a scholar of the Reproductive Scientist Development Program. |
Jayanthi S. Lea, M.D. |
|
 |
Dr. Lea cares for patients with all types of gynecologic cancers. In addition, she is involved in several clinical trials, the teaching of medical students, residents, and fellows and has lectured and published on gynecologic oncology.
|
|
|
Dr. Nishida joined the Department of Obstetrics and Gynecology as an Assistant Professor in 2006 after completing a three-year fellowship in gynecologic oncology at the University of Pennsylvania in Philadelphia where she was a Clinical Instructor.
Graduating with honors from Harvard University with a bachelor’s degree in biology, Dr. Nishida received her medical degree from the University of California, San Diego School of Medicine at La Jolla in 1999. She followed this with a four-year residency in obstetrics and gynecology at University of Southern California's County Women’s and Children’s Hospital and was the recipient of the Berlex Laboratories Best Second Year Teaching Resident Award.
An active candidate with the American Board of Obstetrics and Gynecology, Dr. Nishida is a member of the American College of Obstetricians and Gynecologists, the Society of Gynecologic Oncologists, the American Association of Gynecologic Laparoscopists, and the American Medical Association. She is active in cancer research and participates in the cancer-treatment protocols of the Gynecologic Oncology Group.
Dr. Nishida is a member of the team of gynecologic oncologists treating women at the Simmons Comprehensive Cancer Center.
|
Karen Nishida, M.D. |
| |
|
|
| |
|
|
| |
|
| |
|
| |
|
| |
|
To make an appointment, please call 214-645-4673
Gynecologic Oncology
Seay Biomedical Building
2201 Inwood Rd., Second Floor
Dallas, Texas 75390-9125
|
| |
|
|
